Imatinib and ruxolitinib association: first experience in two patients

Haematologica. 2014 Jun;99(6):e76-7. doi: 10.3324/haematol.2013.102525. Epub 2014 Mar 14.
No abstract available

Keywords: chronic myeloid leukemia; imatinib; myelofibrosis; post-polycythemia vera; ruxolitinib.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides / adverse effects*
  • Benzamides / therapeutic use
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
  • Male
  • Middle Aged
  • Nitriles
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Polycythemia Vera / complications
  • Primary Myelofibrosis / complications*
  • Primary Myelofibrosis / drug therapy
  • Primary Myelofibrosis / etiology
  • Pyrazoles / adverse effects*
  • Pyrazoles / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use

Substances

  • Benzamides
  • Nitriles
  • Piperazines
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • Imatinib Mesylate